Annual Accounts Payable
$1.34 M
-$704.00 K-34.51%
31 December 2023
Summary:
AcelRx Pharmaceuticals annual accounts payable is currently $1.34 million, with the most recent change of -$704.00 thousand (-34.51%) on 31 December 2023. During the last 3 years, it has fallen by -$785.00 thousand (-37.01%).ACRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.34 M
+$310.00 K+30.21%
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly accounts payable is currently $1.34 million, with the most recent change of +$310.00 thousand (+30.21%) on 31 December 2023.ACRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -37.0% | -37.0% |
| 5 y5 years | -22.3% | -22.3% |
ACRX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -51.2% | -66.1% |
AcelRx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.34 M(-34.5%) | $1.34 M(+30.2%) |
| Sept 2023 | - | $1.03 M(-15.3%) |
| June 2023 | - | $1.21 M(-13.3%) |
| Mar 2023 | - | $1.40 M(-31.5%) |
| Dec 2022 | $2.04 M(-3.8%) | $2.04 M(+1.8%) |
| Sept 2022 | - | $2.00 M(-16.5%) |
| June 2022 | - | $2.40 M(-11.6%) |
| Mar 2022 | - | $2.71 M(+28.0%) |
| Dec 2021 | $2.12 M(-22.5%) | $2.12 M(-4.8%) |
| Sept 2021 | - | $2.23 M(+14.8%) |
| June 2021 | - | $1.94 M(-40.0%) |
| Mar 2021 | - | $3.23 M(+18.2%) |
| Dec 2020 | $2.74 M(+59.1%) | $2.74 M(+37.0%) |
| Sept 2020 | - | $2.00 M(-16.6%) |
| June 2020 | - | $2.40 M(-26.3%) |
| Mar 2020 | - | $3.25 M(+88.8%) |
| Dec 2019 | $1.72 M(-16.9%) | $1.72 M(-35.1%) |
| Sept 2019 | - | $2.65 M(+13.5%) |
| June 2019 | - | $2.33 M(-36.9%) |
| Mar 2019 | - | $3.70 M(+78.6%) |
| Dec 2018 | $2.07 M(+45.4%) | $2.07 M(+16.6%) |
| Sept 2018 | - | $1.77 M(-1.6%) |
| June 2018 | - | $1.80 M(-21.6%) |
| Mar 2018 | - | $2.30 M(+61.5%) |
| Dec 2017 | $1.42 M(-8.6%) | $1.42 M(+14.3%) |
| Sept 2017 | - | $1.25 M(+21.2%) |
| June 2017 | - | $1.03 M(-39.1%) |
| Mar 2017 | - | $1.69 M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $1.56 M(-0.2%) | $1.56 M(+15.3%) |
| Sept 2016 | - | $1.35 M(-52.7%) |
| June 2016 | - | $2.86 M(-20.6%) |
| Mar 2016 | - | $3.60 M(+130.6%) |
| Dec 2015 | $1.56 M(-35.8%) | $1.56 M(-8.2%) |
| Sept 2015 | - | $1.70 M(+6.5%) |
| June 2015 | - | $1.60 M(-40.5%) |
| Mar 2015 | - | $2.69 M(+10.4%) |
| Dec 2014 | $2.43 M(+3.8%) | $2.43 M(-15.3%) |
| Sept 2014 | - | $2.87 M(+2.5%) |
| June 2014 | - | $2.80 M(+28.1%) |
| Mar 2014 | - | $2.19 M(-6.7%) |
| Dec 2013 | $2.34 M(+4.7%) | $2.34 M(+87.6%) |
| Sept 2013 | - | $1.25 M(-3.9%) |
| June 2013 | - | $1.30 M(-67.1%) |
| Mar 2013 | - | $3.94 M(+76.3%) |
| Dec 2012 | $2.23 M(+46.1%) | $2.23 M(-21.8%) |
| Sept 2012 | - | $2.86 M(+138.8%) |
| June 2012 | - | $1.20 M(+5.5%) |
| Mar 2012 | - | $1.14 M(-25.8%) |
| Dec 2011 | $1.53 M(+181.8%) | $1.53 M(-41.7%) |
| Sept 2011 | - | $2.63 M(+42.2%) |
| June 2011 | - | $1.85 M(+41.1%) |
| Mar 2011 | - | $1.31 M(+141.1%) |
| Dec 2010 | $543.00 K(-40.8%) | $543.00 K(-9.8%) |
| Sept 2010 | - | $602.00 K(-34.4%) |
| Dec 2009 | $917.00 K(-22.8%) | $917.00 K |
| Dec 2008 | $1.19 M | - |
FAQ
- What is AcelRx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for AcelRx Pharmaceuticals?
- What is AcelRx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for AcelRx Pharmaceuticals?
What is AcelRx Pharmaceuticals annual accounts payable?
The current annual accounts payable of ACRX is $1.34 M
What is the all time high annual accounts payable for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual accounts payable is $2.74 M
What is AcelRx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ACRX is $1.34 M
What is the all time high quarterly accounts payable for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly accounts payable is $3.94 M